LuxAlgo Global, LLC – Trademark Portfolio
Entity Type: 16
LuxAlgo Global, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include LA, LUXALGO, OSCILLATOR MATRIX, SIGNALS & OVERLAYS, and PRICE ACTION CONCEPTS. The owner is based in Danvers, MA.
230 Independence Way STE 1 #1089
Danvers, MA 01923
Showing of trademarks Trademarks
Trademark Classifications
LuxAlgo Global, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LuxAlgo Global, LLC have?
LuxAlgo Global, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending, 2 abandoned.
What trademark classes does LuxAlgo Global, LLC file in?
LuxAlgo Global, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LuxAlgo Global, LLC's most well-known trademarks?
LuxAlgo Global, LLC's registered trademark portfolio includes well-known marks such as LA, LUXALGO, OSCILLATOR MATRIX, SIGNALS & OVERLAYS, and PRICE ACTION CONCEPTS. These are among 6 currently registered trademarks in the portfolio.
What is LuxAlgo Global, LLC's trademark registration success rate?
LuxAlgo Global, LLC has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 2 applications are pending review.